Keyosha Gaines
Medical Oncology · Nashville, TNNPI 1396319174
Payments from drug & device makers
Across 91 payments — averaging $35.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$411
- Johnson & Johnson$337
- Gilead$293
- Regeneron Healthcare Solutions, Inc.$241
- Seagen Inc.$220
- AbbVie$205
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,75586%
- Education$43614%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 12 | $411 |
| Johnson & Johnson(2 entities) | 10 | $337 |
| Gilead | 6 | $293 |
| Regeneron Healthcare Solutions, Inc. | 7 | $241 |
| Seagen Inc. | 3 | $220 |
| AbbVie | 5 | $205 |
| Lilly USA, LLC | 4 | $172 |
| E.r. Squibb & Sons, L.L.C. | 3 | $157 |
| Emmaus Medical, Inc. | 6 | $153 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $150 |
| Sanofi | 1 | $97 |
| Daiichi Sankyo Inc. | 3 | $84 |
| Bristol Myers Squibb | 3 | $73 |
| Genentech USA, Inc. | 3 | $59 |
| UCB, Inc. | 2 | $55 |
| Genentech, Inc. | 1 | $51 |
| Novartis | 2 | $45 |
| Array Biopharma Inc | 2 | $43 |
| Dendreon Pharmaceuticals LLC | 1 | $34 |
| Bayer | 2 | $32 |
| Karyopharm Therapeutics Inc. | 1 | $28 |
| Sun Pharmaceutical Industries Inc. | 1 | $28 |
| Pfizer | 1 | $26 |
| Merck | 1 | $26 |
| Beigene USA, Inc. | 1 | $24 |
| Incyte Corporation | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Tempus AI, Inc | 1 | $23 |
| GSK | 1 | $21 |
| Beone Medicines USA, Inc. | 1 | $21 |
| Exelixis Inc. | 1 | $20 |
| Amgen | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,191 in reported general payments places this provider in the 30th percentile of 101 medical oncology providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 23 | $935 |
| Ondansetron OdtOndansetron | 12 | $294 |
| Anastrozole | 23 | $184 |
| Gabapentin | 16 | $58 |
| Prednisone | 11 | $34 |
Paid to pharmacies, not to this prescriber.
Other medical oncology in Nashville
- Melissa JohnsonNashville$46M
- David SpigelNashville$29.7M
- Howard BurrisNashville$12.2M
- Ingrid MayerNashville$6.3M
- Jennifer ChoeNashville$4.1M
- Cathy EngNashville$3.8M
- Jordan BerlinNashville$3.7M
- Kristen CiomborNashville$3.2M
- Vandana AbramsonNashville$3M
- Leora HornNashville$2.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.